aspsirna0326 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0326
siRNA Name: siCOL7 G2043R mut11
Gene:Collagen type VII alpha 1 (COL7A1)
Disease:Dominant dystrophic epidermolysis bullosa(DDEB)
Wild allele/target (5'->3'): GUAUUCCCGGGCUCCCAGG
Mutant allele/target (5'->3'):GUAUUCCCAGGCUCCCAGG
Target Mutation: c.6127G>A,p.Gly2043Arg
Wild siRNA (As strand):CAUAAGGGCCCGAGGGUCC
ASP-siRNA (As strand):CAUAAGGGUCCGAGGGUCC
Mismatch position in siRNA: U9C
Mutant allele (5'->3'): GUAUUCCCAGGCUCCCAGG
ASP-siRNA (As strand):CAUAAGGGUCCGAGGGUCC
ASP-siRNA efficacy for mutant allele:23
Wild allele (5'->3'): GUAUUCCCGGGCUCCCAGG
ASP-siRNA (As strand):CAUAAGGGUCCGAGGGUCC
ASP-siRNA efficacy for wild allele:5
Percentage discrimination for ASP-siRNA:18
Wild allele (5'->3'): GUAUUCCCGGGCUCCCAGG
Wild siRNA (As strand):CAUAAGGGCCCGAGGGUCC
Wild sirna efficacy for wild allele:70
Wild allele (5'->3'): GUAUUCCCGGGCUCCCAGG
ASP-siRNA (As strand):CAUAAGGGUCCGAGGGUCC
Wild sirna efficacy for mutant allele:88
Percentage discrimination for wild siRNA:-18
Concentration:10nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q02388
Target sequence: GGAAAGCCUGGUAUUCCCGGGCUCCCAGGCAGGGCUG
Genbank Accesion: NM_000094.3
Cell-line: 293T
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Invitrogen,Sigma
Post-transfection duration: 48 hours
OMID ID: 131750
KEGG disease ID:H00584
Reference:22336946

.
.
.
.
.
.
.
.
.
.
.

.

.

.